Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Musso

Showing results (61-70 of 138) with videos related to

Pageof 14
Sort By:
Eye (London, England)|July 7, 2005
Cyclotorsional eye movements during a simulated PRK procedureA M Fea, L Sciandra, F Annetta, et al.
Archivos Argentinos De Pediatria|March 1, 1970
[Lowe's syndrome]F De Elizalde, C Cambiano, J C Gravano, et al.
Leukemia & Lymphoma|December 1, 1993
H and L ferritin gene expression in U937 cells induced to macrophage differentiationG Bianchi-Scarrá, M Musso, G Cutrona, et al.
Haematologica|July 1, 1994
Effects of R-enantiomer (GR66234A) and L-enantiomer (GR66235A) of telupidine, a new dihydropyridine derivative, on cell lines displaying the multidrug resistant phenotypeM Tolomeo, R A Gancitano, M Musso, et al.
Biochemical and Biophysical Research Communications|September 25, 1995
Characterization of a distal 5'-flanking region (-2010/-630) of human GM-CSFP Fiorentini, M Musso, S Penco, et al.
Medicina|January 1, 1983
[Acquired immunodeficiency syndrome (AIDS) with Kaposi's sarcoma in homosexuals in Argentina]M E Estevez, S Bruno, L Sen, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Comparative activity of idarubicin and idarubicinol in combination with cyclosporin A in multidrug-resistant leukemia cellsM Tolomeo, R A Gancitano, M Musso, et al.
Development (Cambridge, England)|May 4, 2023
The exon junction complex component EIF4A3 is essential for mouse and human cortical progenitor mitosis and neurogenesisBianca M Lupan, Rachel A Solecki, Camila M Musso, et al.
Haematologica|December 24, 1997
Low-dose long-term oral idarubicin in maintenance treatment of elderly acute myeloid leukemiaM Musso, F Porretto, A Crescimanno, et al.
Haematologica|January 1, 1989
Double-stranded RNA excess in hematologic diseases: clinical implicationsM Musso, V Abbadessa, R Perricone, et al.
Pageof 14

Showing results (61-70 of 138) with videos related to

Sort By:
Pageof 14
Eye (London, England)|July 7, 2005
Cyclotorsional eye movements during a simulated PRK procedureA M Fea, L Sciandra, F Annetta, et al.
Archivos Argentinos De Pediatria|March 1, 1970
[Lowe's syndrome]F De Elizalde, C Cambiano, J C Gravano, et al.
Leukemia & Lymphoma|December 1, 1993
H and L ferritin gene expression in U937 cells induced to macrophage differentiationG Bianchi-Scarrá, M Musso, G Cutrona, et al.
Haematologica|July 1, 1994
Effects of R-enantiomer (GR66234A) and L-enantiomer (GR66235A) of telupidine, a new dihydropyridine derivative, on cell lines displaying the multidrug resistant phenotypeM Tolomeo, R A Gancitano, M Musso, et al.
Biochemical and Biophysical Research Communications|September 25, 1995
Characterization of a distal 5'-flanking region (-2010/-630) of human GM-CSFP Fiorentini, M Musso, S Penco, et al.
Medicina|January 1, 1983
[Acquired immunodeficiency syndrome (AIDS) with Kaposi's sarcoma in homosexuals in Argentina]M E Estevez, S Bruno, L Sen, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Comparative activity of idarubicin and idarubicinol in combination with cyclosporin A in multidrug-resistant leukemia cellsM Tolomeo, R A Gancitano, M Musso, et al.
Development (Cambridge, England)|May 4, 2023
The exon junction complex component EIF4A3 is essential for mouse and human cortical progenitor mitosis and neurogenesisBianca M Lupan, Rachel A Solecki, Camila M Musso, et al.
Haematologica|December 24, 1997
Low-dose long-term oral idarubicin in maintenance treatment of elderly acute myeloid leukemiaM Musso, F Porretto, A Crescimanno, et al.
Haematologica|January 1, 1989
Double-stranded RNA excess in hematologic diseases: clinical implicationsM Musso, V Abbadessa, R Perricone, et al.
Pageof 14